2-pyrrolino-dox has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagy, A; Schally, AV | 1 |
| Armatis, P; Groot, K; Halmos, G; Horvath, J; Jungwirth, A; Kovacs, M; Miyazaki, M; Nagy, A; Schally, AV; Szepeshazi, K; Zarandi, M | 1 |
| Groot, K; Halmos, G; Hebert, F; Kahán, Z; Nagy, A; Schally, AV; Sun, B | 1 |
| Arencibia, JM; Groot, K; Halmos, G; Kahán, Z; Nagy, A; Schally, AV | 1 |
1 review(s) available for 2-pyrrolino-dox and Breast Cancer
| Article | Year |
|---|---|
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Endometrial Neoplasms; Epithelial Cells; Female; Gonadotropin-Releasing Hormone; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Pyrroles; Receptors, LHRH | 2005 |
3 other study(ies) available for 2-pyrrolino-dox and Breast Cancer
| Article | Year |
|---|---|
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
Topics: Amino Acid Sequence; Animals; Antibiotics, Antineoplastic; Binding, Competitive; Breast Neoplasms; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Molecular Sequence Data; Pituitary Gland; Pyrroles; Rats; Receptors, LHRH; Tumor Cells, Cultured | 1996 |
Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Division; Doxorubicin; Female; Growth Hormone; Humans; Immunotoxins; Luteinizing Hormone; Mice; Mice, Nude; Pyrroles; Receptors, Somatostatin; Transplantation, Heterologous | 1999 |
Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; DNA Primers; Doxorubicin; Drug Delivery Systems; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Radioligand Assay; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 2000 |